(Total Views: 465)
Posted On: 07/22/2021 7:14:54 PM
Post# of 153915
Re: Good to go #97031
We won't see the contracts but work product belonging to the company is standard boilerplate. By filing the patent Patterson may have also violated his non-disclosure agreement.
Doing an interim on NASH really doesn't carry a penalty since it's a phase 2 trial. Whether it's worthwhile would depend on how many patients we have that completed the trial. If we have 30 a preliminary look could aid the rest of the trial and if the results are excellent the FDA may allow us to go to phase 3. At worst we know how things are progressing at best we can get to phase 3 faster.
The best science presenters can break it down to simplistic terms and can add some pizazz. In the process you lose the complexity of the science. I'm fine with how Dr. Recknor presents because I'd rather have the actual science.
Doing an interim on NASH really doesn't carry a penalty since it's a phase 2 trial. Whether it's worthwhile would depend on how many patients we have that completed the trial. If we have 30 a preliminary look could aid the rest of the trial and if the results are excellent the FDA may allow us to go to phase 3. At worst we know how things are progressing at best we can get to phase 3 faster.
The best science presenters can break it down to simplistic terms and can add some pizazz. In the process you lose the complexity of the science. I'm fine with how Dr. Recknor presents because I'd rather have the actual science.
(13)
(0)
